Skip to Main Content
Try STAT+ TODAY
Trending:
Health
Biotech
STAT+
Pharma
Subscribe Now To access exclusive content, subscribe to STAT+
View Latest View the latest STAT+ stories
Biotech
STAT+

‘Every man and his dog’ does cell therapy. Vor’s new CEO says the company wants to be different

  • Kate Sheridan

By Kate Sheridan Aug. 7, 2019

Reprints
Human T lymphocyte
Scanning electron micrograph of a T cell from the immune system of a healthy donor. NIAID

Three years after Pulitzer Prize-winning writer and oncologist Dr. Siddhartha Mukherjee founded Vor Biopharma, the company finally has its first executive.

Robert Ang, formerly the chief business officer for Neon Therapeutics, will be Vor’s first chief executive officer, the company announced Wednesday.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED

About the Author Reprints

Kate Sheridan

Kate Sheridan

Research Reporter

Kate collects and analyzes documents, data, and other information for biotech, health tech, science, and politics stories.

Tags

Eye drops linked to U.S. drug-resistant bacteria outbreak
Eye drops linked to U.S. drug-resistant bacteria outbreak
Medicare Advantage insurers to repay billions under final federal…
Medicare Advantage insurers to repay billions under final federal audit rule
Pharmalittle: ALS Association and its chapters battle over money…
Pharmalittle: ALS Association and its chapters battle over money and priorities; eye drops recalled over links…
They were the 10% left out of life-changing treatments.…
They were the 10% left out of life-changing treatments. Now these cystic fibrosis patients may finally…
Leading ALS advocacy group roiled by infighting over money…
Leading ALS advocacy group roiled by infighting over money and priorities
Teva quits brand lobby PhRMA, in line to lead…
Teva quits brand lobby PhRMA, in line to lead generic lobby AAM

Recommended Stories